Quantum Capital Management (California)’s iShares Biotechnology ETF IBB Stock Holding History

Quantum Capital Management (California)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$24K	Hold	180	–	–	0.03%	192
2020 Q2	$25K	Hold	180	–	–	0.01%	255
2020 Q1	$19K	Hold	180	–	–	0.01%	270
2019 Q4	$22K	Hold	180	–	–	0.01%	289
2019 Q3	$18K	Buy	+180	New	+$18.8K	0.01%	295
2014 Q1	–	Sell	-180	Closed	-$14K	–	196
2013 Q4	$14K	Buy	+180	New	+$12.8K	﹤0.01%	199

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Quantum Capital Management (California)'s IBB Position: Q3 2020 in Review

Quantum Capital Management (California) held its iShares Biotechnology ETF (IBB) position steady in Q3 2020 at 180 shares worth $24K. The position accounts for 0.03% of the portfolio, ranked #192.

Quantum Capital Management (California) first reported a position in IBB in Q4 2013 and has held it in 6 quarters since. The position peaked at $25K in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Quantum Capital Management (California) held 180 shares of iShares Biotechnology ETF worth $24K as of Q3 2020.
Quantum Capital Management (California) left its iShares Biotechnology ETF share count unchanged in Q3 2020.
iShares Biotechnology ETF made up 0.03% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #192 holding.
Quantum Capital Management (California) first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 6 quarters since.
Quantum Capital Management (California)'s iShares Biotechnology ETF position peaked at $25K in Q2 2020.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.